Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

Pfizer shares rose slightly in premarket trading after the company delivered a first-quarter earnings beat and reaffirmed its full-year outlook. The drugmaker posted adjusted earnings of 75 cents a share, ahead of the 72 cents Wall Street had forecast.

Pfizer reaffirmed its full-year guidance, which it initially provided in December.